Terms: = Liver cancer AND PDGFB, SIS, 5155, ENSG00000100311, FLJ12858, PDGF2, P01127, c-sis, SSV AND Prognosis
5 results:
1. Cross-talk between gastric cancer and hepatic stellate cells promotes invadopodia formation during liver metastasis.
Ren C; Yang Z; Xu E; Kang X; Wang X; Sun Q; Wang C; Zhang L; Miao J; Luo B; Chen K; Liu S; Shen X; Lu X; Yin K; Wang M; Xia X; Guan W
Cancer Sci; 2024 Feb; 115(2):369-384. PubMed ID: 38050654
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic significance of systemic inflammation score in patients who undergo hepatic resection for hepatocellular carcinoma.
Inokuchi S; Itoh S; Yoshizumi T; Morinaga A; Toshima T; Takeishi K; Nagao Y; Harada N; Ikegami T; Shimokawa M; Mori M
Langenbecks Arch Surg; 2021 May; 406(3):773-779. PubMed ID: 33595705
[TBL] [Abstract] [Full Text] [Related]
3. Co-expression of PDGF-B and VEGFR-3 strongly correlates with poor prognosis in hepatocellular carcinoma patients after hepatectomy.
Chen B; Liu J; Wang X; Shen Q; Li C; Dai C
Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):126-133. PubMed ID: 29273278
[TBL] [Abstract] [Full Text] [Related]
4. [Nonautonomous effects of oncogenic YAP in hepatocarcinogenesis].
Marquard S; Thomann S; Weiler SME; Sticht C; Gretz N; Schirmacher P; Breuhahn K
Pathologe; 2017 Nov; 38(Suppl 2):175-179. PubMed ID: 29018944
[TBL] [Abstract] [Full Text] [Related]
5. Regression/eradication of gliomas in mice by a systemically-deliverable ATF5 dominant-negative peptide.
Cates CC; Arias AD; Nakayama Wong LS; Lamé MW; Sidorov M; Cayanan G; Rowland DJ; Fung J; Karpel-Massler G; Siegelin MD; Greene LA; Angelastro JM
Oncotarget; 2016 Mar; 7(11):12718-30. PubMed ID: 26863637
[TBL] [Abstract] [Full Text] [Related]